Trump has approved a plan to remove FDA Commissioner Marty Makary, though no final dismissal has been announced
The Facts
- President Donald Trump has signed off on a plan to remove FDA Commissioner Marty Makary.
- Makary had not been formally dismissed at the time of these reports, and several sources said the plan could still change.
- Reported points of conflict included flavored vaping product approvals, oversight of the abortion pill mifepristone, and disputes tied to drug review decisions.
- Makary was confirmed as FDA commissioner in March 2025 and has been identified in coverage as an ally of Robert F. Kennedy Jr.'s Make America Healthy Again movement.
- The possible leadership change matters because the FDA is a major federal regulator overseeing drugs, food and tobacco products, and the administration is weighing who could run the agency next.
- Reuters reported that the White House is considering FDA Deputy Commissioner Kyle Diamantas as acting commissioner, while Stephen Hahn and Brett Giroir are among names being discussed for the permanent role.
How left and right are reading this
- Both agree
- Leadership at the FDA will shape consequential decisions across drugs, food and tobacco, and a commissioner’s possible ouster so soon after confirmation signals that internal disputes over major regulatory calls carry real policy stakes.
- They split on
- Whether the story is about the FDA’s standards being destabilized by political fights over vaping, mifepristone and drug reviews, or about a president installing leadership that will reliably carry out his priorities at a powerful regulator.
Context
Why is Makary's position in doubt?
Reports say Trump and other administration figures had grown frustrated with Makary over the pace of flavored vape approvals, his handling of mifepristone policy, and some drug review decisions that drew criticism from industry and political allies NYT POLITICO CNN International.
Has Trump actually fired Makary yet?
Not according to the reports cited here. Several outlets said Trump had approved a plan to remove Makary, but also said no formal dismissal had occurred and that the decision could still change Reuters Bloomberg Business CNN International.
Who could lead the FDA if Makary leaves?
Reuters reported that the White House is considering FDA Deputy Commissioner Kyle Diamantas as acting commissioner, and that former FDA Commissioner Stephen Hahn and former acting commissioner Brett Giroir are among possible nominees for the job Reuters U.S. News & World R….
View all 75 sources
Wire services (7)
Independent coverage (50)
About these frames
See this differently than someone you know would? Two ways to keep it going.
The dial works on any URL — paste an article you read elsewhere this week.